Signaling Mutations Negate the Favorable Impact of <scp> <i>NPM1</i> </scp> Mutations in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With <scp>VEN</scp> / <scp>HMA</scp>

Fieke W. Hoff, Joshua F. Zeidner, Geeta Torlapati, Deedra Nicolet, Krzysztof Mrózek, Ying Huang, Alexander Li, Rina Li Welkie, Ronan T. Swords, Elie Traer, Eytan M. Stein, Tara L. Lin, Maria R. Baer, Vu H. Duong, William G. Blum, Martha L. Arellano, Wendy Stock, Olatoyosi Odenike, Rebecca L. Olin, Catherine C. Smith, Gary J. Schiller, Emily K. Curran, Onyee Chan, Christine McMahon, Michael Hochman, Kieran Sahasrabudhe, Charles Foucar, Jesus Gonzalez‐Lugo, Brittany Knick Ragon, Shivani V. Handa, Nyla A. Heerema, Timothy Chen, Molly Martycz, Mona Stefanos, Sonja G. Marcus, Leonard Rosenberg, Brian J. Druker, Ross L. Levine, Amy Burd, Ashley O. Yocum, Uma M. Borate, Alice S. Mims, Ann‐Katrin Eisfeld, John C. Byrd, Yazan F. Madanat

Open source

DOI
10.1002/ajh.70419
Published
2026-07-02
Container
American Journal of Hematology
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/ajh.70419,
  title = {Signaling Mutations Negate the Favorable Impact of
                    <scp>
                      <i>NPM1</i>
                    </scp>
                    Mutations in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With
                    <scp>VEN</scp>
                    /
                    <scp>HMA</scp>},
  author = {Fieke W. Hoff and Joshua F. Zeidner and Geeta Torlapati and Deedra Nicolet and Krzysztof Mrózek and Ying Huang and Alexander Li and Rina Li Welkie and Ronan T. Swords and Elie Traer and Eytan M. Stein and Tara L. Lin and Maria R. Baer and Vu H. Duong and William G. Blum and Martha L. Arellano and Wendy Stock and Olatoyosi Odenike and Rebecca L. Olin and Catherine C. Smith and Gary J. Schiller and Emily K. Curran and Onyee Chan and Christine McMahon and Michael Hochman and Kieran Sahasrabudhe and Charles Foucar and Jesus Gonzalez‐Lugo and Brittany Knick Ragon and Shivani V. Handa and Nyla A. Heerema and Timothy Chen and Molly Martycz and Mona Stefanos and Sonja G. Marcus and Leonard Rosenberg and Brian J. Druker and Ross L. Levine and Amy Burd and Ashley O. Yocum and Uma M. Borate and Alice S. Mims and Ann‐Katrin Eisfeld and John C. Byrd and Yazan F. Madanat},
  year = {2026},
  journal = {American Journal of Hematology},
  doi = {10.1002/ajh.70419},
  url = {https://doi.org/10.1002/ajh.70419}
}

RIS

TY  - JOUR
TI  - Signaling Mutations Negate the Favorable Impact of
                    <scp>
                      <i>NPM1</i>
                    </scp>
                    Mutations in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With
                    <scp>VEN</scp>
                    /
                    <scp>HMA</scp>
AU  - Fieke W. Hoff
AU  - Joshua F. Zeidner
AU  - Geeta Torlapati
AU  - Deedra Nicolet
AU  - Krzysztof Mrózek
AU  - Ying Huang
AU  - Alexander Li
AU  - Rina Li Welkie
AU  - Ronan T. Swords
AU  - Elie Traer
AU  - Eytan M. Stein
AU  - Tara L. Lin
AU  - Maria R. Baer
AU  - Vu H. Duong
AU  - William G. Blum
AU  - Martha L. Arellano
AU  - Wendy Stock
AU  - Olatoyosi Odenike
AU  - Rebecca L. Olin
AU  - Catherine C. Smith
AU  - Gary J. Schiller
AU  - Emily K. Curran
AU  - Onyee Chan
AU  - Christine McMahon
AU  - Michael Hochman
AU  - Kieran Sahasrabudhe
AU  - Charles Foucar
AU  - Jesus Gonzalez‐Lugo
AU  - Brittany Knick Ragon
AU  - Shivani V. Handa
AU  - Nyla A. Heerema
AU  - Timothy Chen
AU  - Molly Martycz
AU  - Mona Stefanos
AU  - Sonja G. Marcus
AU  - Leonard Rosenberg
AU  - Brian J. Druker
AU  - Ross L. Levine
AU  - Amy Burd
AU  - Ashley O. Yocum
AU  - Uma M. Borate
AU  - Alice S. Mims
AU  - Ann‐Katrin Eisfeld
AU  - John C. Byrd
AU  - Yazan F. Madanat
PY  - 2026
JO  - American Journal of Hematology
DO  - 10.1002/ajh.70419
UR  - https://doi.org/10.1002/ajh.70419
ER  - 

APA

Hoff, F. W., Zeidner, J. F., Torlapati, G., Nicolet, D., Mrózek, K., Huang, Y., Li, A., Welkie, R. L., Swords, R. T., Traer, E., Stein, E. M., Lin, T. L., Baer, M. R., Duong, V. H., Blum, W. G., Arellano, M. L., Stock, W., Odenike, O., Olin, R. L., Smith, C. C., Schiller, G. J., Curran, E. K., Chan, O., McMahon, C., Hochman, M., Sahasrabudhe, K., Foucar, C., Gonzalez‐Lugo, J., Ragon, B. K., Handa, S. V., Heerema, N. A., Chen, T., Martycz, M., Stefanos, M., Marcus, S. G., Rosenberg, L., Druker, B. J., Levine, R. L., Burd, A., Yocum, A. O., Borate, U. M., Mims, A. S., Eisfeld, A., Byrd, J. C., & Madanat, Y. F. (2026). Signaling Mutations Negate the Favorable Impact of <scp> <i>NPM1</i> </scp> Mutations in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With <scp>VEN</scp> / <scp>HMA</scp>. American Journal of Hematology. https://doi.org/10.1002/ajh.70419

Source records